Brieflands
Journal finderSearch
·
Sign in

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408
p-ISSN 1735-143X
Home
Articles
    Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
About Journal
    Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit manuscript
  1. Brieflands
  2. /
  3. journals
  4. /
  5. Hepatitis Monthly
  6. /
  7. Articles
  8. /
  9. Direct-Acting Antivirals Ombitasvir / Paritaprevir / Ritonavir + Dasabuvir with or Without Ribavirin in Hepatitis C Virus (HCV) Genotype 1-Infected Treatment-Naive or Treatment-Experienced Patients with or Without Cirrhosis: Real-Life Experience in Lithuania and Latvia
  10. /
  11. Scopus by Title (Ref)
Citation data

Scopus by Title (Ref)

Articles that cite the referenced work, matched by title from the Scopus database.

3 results·Updated October 24, 2026
← Back to article
1

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons

Viruses

March 2022

Flisiak R.

Open Access

2

High success rates for the use of ombitasvir/paritaprevir/ritonavir containing regimens in treatment of naïve and experienced chronic hepatitis C genotype 4: Real world results

Journal of Medical Virology

February 2022

El Kassas M.

3

Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience

Turkish Journal of Gastroenterology

May 2020

Aygen B.

Open Access

Need help?

Editorial, submission and technical questions all go to the same desk.

Submit a ticket
Brieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.